Found 346 matching trials
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)
NAThis cross-sectional study of pathophysiology will bring additional informa...
Location
Centre Jean Perrin
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse
PHASE3Prospective, multi-center, randomized, open label comparative Phase III stu...
Location
University Clinic Ulm
Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer
NAAlthough combination endocrine therapy has been associated with significant...
Location
Allan Blair Cancer Center
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
PHASE1The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
PHASE3RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.
PHASE2The goal of this clinical trial is to learn whether letrozole, a hormone th...
Location
Cancer Care Hospital and Research Centre Foundation
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
PHASE2This research study is evaluating a drug called Palbociclib in combination ...
Location
University of California, San Francisco
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
PHASE2This study is being done to test the safety and effectiveness of two drugs,...
Location
University of Kansas Medical Center
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer
NAPOSNOC is a pragmatic, randomised, multicentre, non-inferiority trial.
Aim...
Status
Active Not Recruiting
Location
Royal Adelaide Hospital
Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
PHASE3This is a prospective, randomized, open-label, multicenter phase III study ...
Location
Zhimin Cancer Shao